BHVN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
124.9M
-4.2%
130.4M
-8.6%
142.7M
-15.7%
169.4M
-20.0%
211.7M
R&D
100.8M
-2.9%
103.8M
-14.9%
121.9M
-13.6%
141.2M
-23.4%
184.4M
SG&A
24.1M
-9.5%
26.6M
+28.0%
20.8M
-26.3%
28.2M
+3.2%
27.3M
Operating Income
-124899000
+4.2%
-130428000
+8.6%
-142734000
+15.7%
-169382000
+20.0%
-211701000
EBITDA
-122640000
+4.2%
-128062000
+8.6%
-140161000
+15.7%
-166257000
+20.7%
-209723000
Net Income
-137311000
-5.2%
-130532000
+10.3%
-145555000
+16.1%
-173443000
+12.5%
-198147000
EPS (Basic)
$-0.91
-3.4%
$-0.88
+27.3%
$-1.21
+26.2%
$-1.64
+15.5%
$-1.94
EPS (Diluted)
$-0.91
-3.4%
$-0.88
+27.3%
$-1.21
+26.2%
$-1.64
+15.5%
$-1.94
Shares (Diluted)
150.6M
+2.0%
147.6M
+22.6%
120.4M
+13.8%
105.8M
+3.4%
102.4M
Biohaven (BHVN) โ€” Financials